GX301

· Laboratoires Leurquin Mediolanum

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for GX301, covering 2020-07-22 to 2020-07-22. Get the full timeline:

Most recent: Clinical Trial Update: A Phase II Randomised Trial of Three Regimens of GX301 Vaccination in Castration-resistant Prostate Cancer [Phase 2]

See pricing